Efficacy and safety of regorafenib dose-escalation therapy for Japanese patients with refractory metastatic colorectal cancer (RECC study) - Ishiyama, Shun; Yamada, Takeshi; Nakamura, Masato; Enomoto, Masanobu; Sugimoto, Kiichi; Yokomizo, Hajime; Kosugi, Chihiro; Ohta, Ryo; Ishimaru, Kei; Sonoda, Hiromichi; Ishibashi, Keiichiro; Kuramochi, Hidekazu; et al. (International journal of clinical oncology, 2022)
Keywords: Adverse events; Cancer; Cancer Research; Cancer therapies; Chemotherapy; Colorectal cancer; Colorectal carcinoma; Disease control; Inhibitor drugs; Liver diseases; Medicine; Medicine & Public Health; Metastases; Metastasis; Oncology; Original Article; Patients; Surgical Oncology; Survival; Targeted cancer therapy; Regorafenib; Japanese patients; Dose-escalation; Colorectal cancer